Semliki Forest virus vectors for overexpression of 101 G protein-coupled receptors in mammalian host cells

Protein Expression and Purification

Volumn 45, Issue 2, 2006, Pages 343-351

  Hassaine, Gherici ^a   Wagner, Renaud ^b   Kempf, Juliette ^b   Cherouati, Nadia ^b   Hassaine, Nouzha ^a   Prual, Cecile ^c   André, Nicolas ^c   Reinhart, Christoph ^c   Pattus, Franc ^b   Lundstrom, Kenneth ^a  

^a BioXtal   (Switzerland)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c MAX PLANCK INSTITUTE OF BIOPHYSICS   (Germany)

Author keywords

Binding assays; G protein coupled receptors; Immunodetection; Large scale production; Mammalian cell lines; Recombinant expression; Semliki Forest virus; Structural biology; Structural genomics

Indexed keywords

G PROTEIN COUPLED RECEPTOR;

ANIMAL; ARTICLE; CELL LINE; CHEMISTRY; CULTURE MEDIUM; EVALUATION; GENE EXPRESSION PROFILING; GENE VECTOR; GENETICS; HAMSTER; HUMAN; METABOLISM; MOLECULAR GENETICS; RADIOASSAY; SEMLIKI FOREST ALPHAVIRUS;

ANIMALS; CELL LINE; CRICETINAE; CULTURE MEDIA; GENE EXPRESSION PROFILING; GENETIC VECTORS; HUMANS; MOLECULAR SEQUENCE DATA; RADIOLIGAND ASSAY; RECEPTORS, G-PROTEIN-COUPLED; SEMLIKI FOREST VIRUS;

MAMMALIA; RABBIT FIBROMA VIRUS; SEMLIKI FOREST VIRUS;

EID: 31044446490     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2005.06.007     Document Type: Article

References (50)

1. W.B. Vanti Patent status of the therapeutically important G protein-coupled receptors Exp. Opin. Ther. Patents 11 2001 1861 1887
2. J. Hodgson Receptor screening and the search for new pharmaceuticals Biotechnology 10 1992 973 980
3. T.L. Blundell, H. Jhoti, and C. Abell High-throughput crystallography for lead discovery in drug design Nat. Rev. Drug Discov. 1 2002 45 54
4. K. Palczewski, T. Kumasaka, T. Hori, C.A. Behnke, F. Motoshima, B.A. Fox, I. Le Trong, D.C. Teller, T. Okada, R.E. Stenkamp, M. Yamamoto, and M. Miyano Crystal structure of rhodopsin: a G protein-coupled receptor Science 289 2000 739 745
5. V. Sarramegna, F. Talmont, P. Demange, and A. Milon Heterologous expression of G protein-coupled receptors: comparison of expression systems from the standpoint of large-scale production and purification Cell. Mol. Life Sci. 60 2003 1529 1546
6. S. Luca, J.F. White, A.K. Sohal, D.V. Filippov, J.H. van Boom, R. Grisshammer, and M. Baldus The conformation of neurotensin bound to its G protein-coupled receptor Proc. Natl. Acad. Sci. USA 2003 10706 10711
7. J.-L. Baneres, A. Martin, P. Hullot, J.P. Girard, J.C. Rossi, and J. Parello Structure-based analysis of GPCR function: conformational adaptation of both agonist and receptor upon leukotriene B4 binding to recombinant BLT1 J. Mol. Biol. 329 2003 801 814
8. H.M. Weiss, W. Haase, H. Michel, and H. Reilander Comparative biochemical and pharmacological characterization of the mouse 5-HT5A 5-hydroxytryptamine receptor and the human beta2-adrenergic receptor produced in the methylotrophic yeast Pichia pastoris Biochem. J. 330 1998 1137 1147
9. K.E. Mazina, C.D. Strader, and T.M. Fong Expression and solubilization of a recombinant human neurokinin-1 receptor in insect cells J. Recept. Res. 14 1994 63 73
10. M. Akermoun, M. Koglin, D. Zvalova-Ioos, N. Folschweiller, S.J. Dowell, K.L. Gearing, Characterization of 16 human G protein-coupled receptors expressed in baculovirus-infected insect cells. Protein Expr. Purif., in press, doi:10.1016/j.pep.2005.04.016.
11. P.J. Reeves, J.M. Kim, and H.G. Khorana Structure and function in rhodopsin: a tetracycline-inducible system in stable mammalian cell lines for high-level expression of opsin mutants Proc. Natl. Acad. Sci. USA 99 2002 13413 13418
12. K. Lundstrom Semliki Forest virus vectors for rapid and high-level expression of integral membrane proteins Biochim. Biophys. Acta 1610 2003 90 96
13. K. Lundstrom, C. Schweitzer, D. Rotmann, D. Hermann, E.M. Schneider, and M.U. Ehrengruber Semliki Forest virus vectors: efficient vehicles for in vitro and in vivo gene delivery FEBS Lett. 504 2001 99 103
14. K. Lundstrom Structural genomics of GPCRs Trends Biotechnol. 23 2005 103 108
15. M. Hoffmann, D. Verzijl, K. Lundstrom, U. Simmen, A.E. Alewijnse, H. Timmerman, and R. Leurs Recombinant Semliki Forest virus for over-expression and pharmacological characterisation of the histamine H(2) receptor in mammalian cells Eur. J. Pharmacol. 427 2001 105 114
16. K. Lundstrom, A. Abenavoli, A. Malgaroli, and M.U. Ehrengruber Novel Semliki Forest virus vectors with reduced cytotoxicity and temperature- sensitivity for long-term enhancement of transgene expression Mol. Ther. 7 2003 202 209
17. K. Lundstrom, Semliki Forest virus vectors for large-scale production of recombinant proteins, Methods Mol. Med. (2003) 76 in: C.A. Machida (Ed.),Viral Vectors for Gene Therapy: Methods and Protocols, Human Press, Totowa, NJ, USA.
18. P. Berglund, M. Sjoberg, H. Garoff, G.J. Atkins, B.J. Sheahan, and P. Liljestrom Semliki Forest virus expression system: production of conditionally infectious recombinant particles Biotechnology (NY) 11 1993 916 920
19. P.A. Hardy, M.J. Mazzini, C. Schweitzer, K. Lundstrom, and L.M. Glode Recombinant Semliki Forest virus infects and kills human prostate cancer cell lines and prostatic duct epithelial cells ex vivo Int. J. Mol. Med. 5 2000 241 245
20. 3 receptor purified from mammalian cells J. Neurochem. 70 1998 824 834
21. K. Lundstrom, A. Mills, G. Buell, E. Allet, N. Adami, and P. Liljestrom High-level expression of the human neurokinin-1 receptor in mammalian cell lines using the Semliki Forest virus expression system Eur. J. Biochem. 224 1994 917 921
22. K. Lundstrom, and M.P. Turpin Proposed schizophrenia-related gene polymorphism: expression of the Ser9Gly mutant human dopamine D3 receptor with the Semliki Forest virus system Biochem. Biophys. Res. Commun. 225 1996 1068 1072
23. K.G. Harikumar, and A. Chattopadhyay Modulation of antagonist binding to serotonin1A receptors from bovine hippocampus by metal ions Cell. Mol. Neurobiol. 21 2001 453 464
24. 3H]-GR-125743, a novel radiolabelled serotonin 5HT1D/1B receptor antagonist Naunyn Schmiedebergs Arch. Pharmacol. 356 1997 328 334
25. V. Audinot, A. Newman-Tancredi, D. Cussac, and M.J. Millan Inverse agonist properties of antipsychotic agents at cloned, human (h) serotonin (5-HT)(1B) and h5-HT(1D) receptors Neuropsychopharmacology 25 2001 410 422
26. N. Adham, P. Romanienko, P. Hartig, R.L. Weinshank, and T. Branchek The rat 5-hydroxytryptamine1B receptor is the species homologue of the human 5-hydroxytryptamine1D beta receptor Mol. Pharmacol. 41 1992 1 7
27. M.J. Millan, A. Newman-Tancredi, V. Audinot, D. Cussac, F. Lejeune, J.P. Nicolas, F. Coge, J.P. Galizzi, J.A. Boutin, J.M. Rivet, A. Dekeyne, and A. Gobert Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors, Significance for the modulation of frontocortical monoaminergic transmission and depressive states Synapse 35 2000 79 95
28. A. Marjamaki, K. Luomala, S. Ala-Uotila, and M. Scheinin Use of recombinant human alpha 2-adrenoceptors to characterize subtype selectively of antagonist binding Eur. J. Pharmacol. 246 1993 219 226
29. K.N. Klotz, J. Hessling, J. Hegler, C. Owman, B. Kull, B.B. Fredholm, and M.J. Lohse Comparative pharmacology of human adenosine receptor subtypes-characterization of stably transfected receptors in CHO cells Naunyn Schmiedebergs Arch. Pharmacol. 357 1998 1 9
30. H.M. Weiss, and R. Grisshammer Purification and characterization of the human adenosine A(2a) receptor functionally expressed in Escherichia coli Eur. J. Biochem. 269 2002 82 92
31. E.G. Peralta, A. Ashkenazi, J.W. Winslow, D.H. Smith, J. Ramachandran, and D.J. Capon Distinct primary structures, ligand-binding properties, and tissue-specific expression of four human muscarinic acetylcholine receptors EMBO J. 6 1987 3923 3929
32. S. Bastian, D. Pruneau, B. Loillier, C. Robert, J.C. Bonnafous, and J.L. Paquet Identification of a key region of kinin B(1) receptor for high affinity binding of peptide antagonists J Biol. Chem. 275 2000 6107 6113
33. P. Hill, Y. Lai, J. Hnilo, C.C. Lin, M. Karla, S. Bounds, J. Herz, and R. Mitchell Cloning, expression, and comparison of the binding characteristics of the known human dopamine receptors Adv. Neurol. 69 1996 41 52
34. 〈 www.euroscreen.be /〉.
35. V.A. Campbell, P. Beddy, A. Foley, Y.S. Bakhle, and C. Bell Reduced inflammation in genetically hypertensive rat airways is associated with reduced tachykinin NK(1) receptor numbers Eur. J. Pharmacol. 401 2000 109 114
36. R. Grisshammer, J. Little, and D. Aharony Expression of rat NK-2 (neurokinin A) receptor in E. coli Receptors Channels 2 1994 295 302
37. F. Oury-Donat, P. Carayon, O. Thurneyssen, V. Pailhon, X. Emonds-Alt, P. Soubrie, and G. Le Fur Functional characterization of the nonpeptide neurokinin3 (NK3) receptor antagonist, SR142801 on the human NK3 receptor expressed in Chinese hamster ovary cells J. Pharmacol. Exp. Ther. 274 1995 148 154
38. C. Cabrele, H.A. Wieland, M. Langer, C.E. Stidsen, and A.G. Beck-Sickinger Y-receptor affinity modulation by the design of pancreatic polypeptide/neuropeptide Y chimera led to Y(5)-receptor ligands with picomolar affinity Peptides 22 2001 365 378
39. K. Befort, L. Tabbara, D. Kling, B. Maigret, and B.L. Kieffer Role of aromatic transmembrane residues of the delta-opioid receptor in ligand recognition J. Biol. Chem. 271 1996 10161 10168
40. A. Tahara, M. Saito, T. Sugimoto, Y. Tomura, K. Wada, T. Kusayama, J. Tsukada, N. Ishii, T. Yatsu, W. Uchida, and A. Tanaka Pharmacological characterization of YM087, a potent, nonpeptide human vasopressin V1A and V2 receptor antagonist Naunyn Schmiedebergs Arch. Pharmacol. 357 1998 63 69
41. M. Kozak Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes Cell 44 1986 283 292
42. K. Lundstrom, A. Vargas, and B. Allet Functional activity of a biotinylated human neurokinin-1 receptor fusion expressed in the Semliki Forest virus system Biochem. Biophys. Res. Commun. 208 1995 260 266
43. K. Lundstrom, and R. Henningsen Semliki Forest virus vectors applied to receptor expression in cell lines and primary neurons J. Neurochem. 71 Suppl. 1 1998 S50D.
44. S. Perri, D.A. Driver, J.P. Gardner, S. Sherrill, B.A. Belli, T.W. Dubensky Jr., and J.M. Polo Replicon vectors derived from Sindbis virus and Semliki Forest virus that establish persistent replication in host cells J. Virol. 74 2000 9802 9807
45. C. Schweitzer, C. Kratzeisen, G. Adam, K. Lundstrom, P. Malherbe, S. Ohresser, H. Stadler, J. Wichmann, T. Woltering, and V. Mutel Characterization of [(3)H]-LY354740 binding to rat mGlu2 and mGlu3 receptors expressed in CHO cells using Semliki Forest virus vectors Neuropharmacology 39 2000 1700 1706
46. H.H. Cramer, K. Schmenger, K. Heinrich, A. Horstmeyer, H. Boning, A. Breit, A. Piiper, K. Lundstrom, W. Muller-Esterl, and C. Schroeder Coupling of endothelin receptors to the ERK/MAP kinase pathway. Roles of palmitoylation and G(alpha)q Eur. J. Biochem. 268 2001 5449 5459
47. 2B-AR green fluorescent fusion protein in mammalian cells using Semliki Forest virus vectors Protein Expr. Purif. 32 2003 265 275
48. K. Lundstrom Semliki forest virus-based expression for versatile use in receptor research J. Recept. Signal Transduct. Res. 22 2002 229 240
49. K. Lundstrom Alphaviruses as tools in neurobiology and gene therapy J. Recept. Signal Transduct. Res. 19 1999 673 686
50. X.M. Guan, T.S. Kobilka, and B.K. Kobilka Enhancement of membrane insertion and function in a type IIIb membrane protein following introduction of a cleavable signal peptide J. Biol. Chem. 267 1992 21995 21998